Network pharmacology analyses of the antithrombotic pharmacological mechanism of Fufang Xueshuantong Capsule with experimental support using disseminated intravascular coagulation rats

Journal of Ethnopharmacology

Volumn 154, Issue 3, 2014, Pages 735-744

  Sheng, Shujing ^a,b   Wang, Jinxu ^a,c   Wang, Lirong ^c   Liu, Hong ^a   Li, Peibo ^a   Liu, Menghua ^a   Long, Chaofeng ^b   Xie, Chengshi ^b   Xie, Xiangqun ^c   Su, Weiwei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Zhongsheng Pharmaceutical Co Ltd   (China)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Disseminated intravascular coagulation; Fufang Xueshuantong Capsule; Network pharmacology; Thrombosis disease

Indexed keywords

ANTICOAGULANT AGENT; FUFANG XUESHUANTONG CAPSULE; HEPARIN; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; FIBRINOLYTIC AGENT; FUFANG XIAOJINGTONG; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTRAGALUS PLANT; BLOOD CLOTTING; CHINESE HERB; CHINESE MEDICINE; CONTROLLED STUDY; DATA BASE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; FIBRINOLYSIS; MALE; MOLECULAR DOCKING; NONHUMAN; PANAX NOTOGINSENG; POLYPHARMACOLOGY; RAT; SALVIA MILTIORRHIZA; SCROPHULARIACEAE; THROMBOCYTE AGGREGATION; THROMBOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DISEASE MODEL; DISSEMINATED INTRAVASCULAR COAGULATION; ISOLATION AND PURIFICATION; MOLECULARLY TARGETED THERAPY; SPRAGUE DAWLEY RAT;

PANAX NOTOGINSENG; RATTUS; SALVIA MILTIORRHIZA; SCROPHULARIACEAE;

ANIMALS; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; DRUGS, CHINESE HERBAL; FIBRINOLYTIC AGENTS; LIPOPOLYSACCHARIDES; MALE; MOLECULAR TARGETED THERAPY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84902539675     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.04.048     Document Type: Article

References (58)

1. K. Aksu, A. Donmez, and G. Keser Inflammation-induced thrombosis: mechanisms, disease associations and management Current Pharmaceutical Design 18 2012 1478 1493
2. H. Asakura, R. Asamura, Y. Ontachi, T. Hayashi, M. Yamazaki, E. Morishita, K.I. Miyamoto, and S. Nakao Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats Journal of Thrombosis and Haemostasis 3 2005 1050 1055
3. H. Asakura, M. Okudaira, T. Yoshida, Y. Ontachi, M. Yamazaki, E. Morishita, K. Miyamoto, and S. Nakao Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats Thrombosis and Haemostasis 88 2002 663 667
4. R.L. Bick Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care Clinical and Applied Thrombosis-Hemostasis 8 2002 1 31
5. D.J. Campbell The renin-angiotensin and the kallikrein-kinin systems International Journal of Biochemistry & Cell Biology 35 2003 784 791
6. G. Cesarman-Maus, and K.A. Hajjar Molecular mechanisms of fibrinolysis British Journal of Haematology 129 2005 307 321
7. J.Z. Chen, J. Wang, and X.Q. Xie GPCR structure-based virtual screening approach for CB2 antagonist search Journal of Chemical Information and Modeling 47 4 2007 1626 1637
8. Y.H. Cho, C.R. Ku, Z.Y. Hong, J.H. Heo, E.H. Kim, D.H. Choi, D. Kim, A.J. Kim, C.S. Lee, M. Jung, H.C. Lee, M. Seo, and E.J. Lee Therapeutic effects of water soluble danshen extracts on atherosclerosis Evidence-Based Complementary and Alternative Medicine 2013 DOI: 10.1155/2013/623639
9. Y.J. Chuang, R. Swanson, S.M. Raja, and S.T. Olson Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin Journal of Biological Chemistry 276 18 2001 14961 14971
10. F. Cipollone, G. Cicolini, and M. Bucci Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives Pharmacology & Therapeutics 118 2008 161 180
11. B. Dahlback Blood coagulation Lancet 355 2000 1627 1632
12. B. Engelmann, and S. Massberg Thrombosis as an intravascular effector of innate immunity Nature Reviews Immunology 13 2013 34 45
13. G.S. Galyautdinov, and Y.L. Zhulyeva Antithrombin III: physiology and clinical significance Gematologiya I Transfuziologiya 47 2002 31 34
14. P.G. Gettins, and S.T. Olson Activation of antithrombin as a factor IXa and Xa inhibitor involves mitigation of repression rather than positive enhancement FEBS Letters 583 21 2009 3397 3400
15. C.E. Hack Derangements of coagulation and fibrinolysis in infectious diseases Tropical Medicine & International Health 10 2003 18 37
16. S. Hagiwara, H. Iwasaka, S. Hidaka, A. Hasegawa, H. Koga, and T. Noguchi Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats Intensive Care Medicine 35 8 2009 1471 1478
17. J. Hirsh, and R. Raschke Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 2004 188S 203S
18. A.L. Hopkins Network pharmacology: the next paradigm in drug discovery Nature Chemical Biology 4 2008 682 690
19. Z.S. Huang, C.L. Zeng, L.J. Zhu, L. Jiang, N. Li, and H. Hu Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase Journal of Thrombosis and Haemostasis 8 2010 1383 1393
20. A.N. Jain Effects of protein conformation in docking: improved pose prediction through protein pocket adaptation Journal of Computer-aided Molecular Design 23 2009 355 374
21. D.B. Kitchen, H. Decornez, J.R. Furr, and J. Bajorath Docking and scoring in virtual screening for drug discovery: Methods and applications Nature Reviews Drug Discovery 3 2004 935 949
22. C.S. Kitchens Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC) The Education Program of the American Society of Hematology 2009 240 246
23. A.J. Lau, D.F. Toh, T.K. Chua, Y.K. Pang, S.O. Woo, and H.L. Koh Antiplatelet and anticoagulant effects of Panax notoginseng: comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium Journal of Ethnopharmacology 125 2009 380 386
24. K. Lee, C.W. Park, W.H. Jung, H.D. Park, S.H. Lee, K.H. Chung, S.K. Park, O.H. Kwon, M. Kang, D.H. Park, S.K. Lee, E.E. Kim, S.K. Yoon, and A. Kim Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d- diphenylalanyl-l-prolyl (5-amidino-2-thienyl)methylamide Journal of Medicinal Chemistry 46 2003 3612 3622
25. M. Levi Pathogenesis and treatment of DIC Thrombosis Research 115 Supplement 1 2005 S54 S55
26. M. Levi, C.H. Toh, J. Thachil, and H.G. Watson Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology British Journal of Haematology 145 2009 24 33
27. B. Li, X. Xu, X. Wang, H. Yu, X. Li, W. Tao, Y. Wang, and L. Yang A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease International Journal of Molecular Sciences 13 2012 13501 13520
28. C.T. Li, H.B. Wang, and B.J. Xu A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2 Pharmaceutical Biology 51 2013 1077 1080
29. S. Li, and B. Zhang Traditional Chinese medicine network pharmacology: theory, methodology and application Chinese Journal of Nature Medicine 11 2013 110 120
30. J.P. Liang, Z.Z. Liu, P. Wei, and S.W. Wei HPLC fingerprint of Compound Xueshuantong Capsule Journal of Chinese Medicinal Materials 35 2012 1854 1858
31. N. Mackman, R.E. Tilley, and N.S. Key Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis Arteriosclerosis Thrombosis and Vascular Biology 27 2007 1687 1693
32. K.G. Mann Biochemistry and physiology of blood coagulation Thrombosis and Haemostasis 82 1999 165 174
33. N. Maugeri, G. Di Fabio, M. Barbanti, G. de Gaetano, M.B. Donati, and C Cerletti Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood Thrombosis and Haemostasis 97 6 2007 965
34. L. Pei, Y. Bao, S. Liu, J. Zheng, and X. Chen Material basis of Chinese herbal formulas explored by combining pharmacokinetics with network pharmacology PLoS One 8 2013 e57414
35. T.A. Pham, and A.N. Jain Customizing scoring functions for docking Journal of Computer-aided Molecular Design 22 2008 269 286
36. R.N. Pike, A.M. Buckle, B.F. le Bonniec, and F.C. Church Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans FEBS Journal 272 2005 4842 4851
37. J.Z. Qi, X. Lin, J.S. Chen, Z.H. Huang, B.T. Qiu, P.X. Qiu, and G.M. Yan A novel fibrinogenase from Agkistrodon acutus venom protects against DIC via direct degradation of thrombosis and activation of protein C Biochemical Pharmacology 84 2012 905 913
38. A.R. Rezaie Heparin-binding exosite of factor Xa Trends in Cardiovascular Medicine 10 8 2000 333 338
39. R.D. Rosenberg Role of heparin and heparinlike molecules in thrombosis and atherosclerosis Federation Proceedings 44 2 1985 404 409
40. P. Shannon, A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T. Ideker Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Research 13 2003 2498 2504
41. S. Schedin-Weiss, B. Richard, and S.T. Olson Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes Archives of Biochemistry and Biophysics 504 2 2010 169 176
42. M. Shiota, H. Kusakabe, Y. Hikita, T. Nakao, Y. Izumi, and H. Iwao Pharmacogenomics of cardiovascular pharmacology: molecular network analysis in pleiotropic effects of statin-an experimental elucidation of the pharmacologic action from protein-protein interaction analysis Journal of Pharmacological Sciences 107 2008 15 19
43. M.E. Smoot, K. Ono, J. Ruscheinski, P.L. Wang, and T. Ideker Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 27 2011 431 432
44. W. Tao, X. Xu, X. Wang, B. Li, Y. Wang, Y. Li, and L. Yang Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease Journal of Ethnopharmacology 145 2013 1 10
45. H. Van Aken, C. Bode, H. Darius, C. Diehm, M. Encke, D.C. Gulba, S. Haas, W. Hacke, W. Puhl, M. Quante, H. Riess, R. Scharf, S. Schellong, K. Schror, K.L. Schulte, and U. Tebbe Anticoagulation: the present and future Clinical and Applied Thrombosis-Hemostasis 7 2001 195 204
46. H. Wada, J. Thachil, M. Di Nisio, P. Mathew, S. Kurosawa, S. Gando, H.K. Kim, J.D. Nielsen, C.E. Dempfle, M. Levi, and C.H. Toh Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines Journal of Thrombosis and Haemostasis 11 4 2013 761 767
47. L. Wang, G.B. Zhou, P. Liu, J.H. Song, Y. Liang, X.J. Yan, F. Xu, B.S. Wang, J.H. Mao, Z.X. Shen, S.J. Chen, and Z. Chen Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia Proceedings of the National Academy of Sciences of the United States of America 105 2008 4826 4831
48. B. Wu, and J. Xu Antithrombotic effect of a novel protein from Fusarium sp. CPCC 480097 in a rat model of artery-vein bypass thrombosis Pharmaceutical Biology 50 2012 866 870
49. X.Q. Xie, J.Z. Chen, and E.M. Billings 3D structural model of the G-protein-coupled cannabinoid CB2 receptor Proteins: Structure, Function, and Genetics 53 2 2003 307 319
50. M.A. Yildirim, K.I. Goh, M.E. Cusick, A.L. Barabási, and M. Vidal Drug-target network Nature Biotechnology 25 2007 1119 1126
51. H. Yu, J. Chen, X. Xu, Y. Li, H. Zhao, Y. Fang, X. Li, W. Zhou, W. Wang, and Y. Wang A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data PLoS One 7 2012 e37608
52. P.X. Yu, Q.J. Zhou, W.W. Zhu, Y.H. Wu, L.C. Wu, X. Lin, M.H. Chen, and B.T. Qiu Effects of quercetin on LPS-induced disseminated intravascular coagulation (DIC) in rabbits Thrombosis Research 131 2013 270 273
53. Y.Z. Yuan, F. Yuan, Q.Y. Xu, J. Yu, L. Li, and J.L. Zhang Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion Chinese Journal of Integrative Medicine 17 2011 296 301
54. H.S. Yun-Choi, M.K. Pyo, K.C. Chang, and D.H. Lee The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats Planta Medica 68 2002 326 329
55. M.F. Zeng, L.M. Pan, S.M. Qi, Y.T. Cao, H.X. Zhu, L.W. Guo, and J. Zhou Systematic review of recent advances in pharmacokinetics of four classical Chinese medicines used for the treatment of cerebrovascular disease Fitoterapia 88 2013 50 75
56. Q. Zhang, X. Xiao, M. Li, W. Li, M. Yu, H. Zhang, X. Sun, L. Mao, and H. Xiang Attenuating effect of Fufang Xueshuantong Capsule on kidney function in diabetic nephropathy model Natural Medicines 67 2013 86 97
57. S. Zhao, and R. Iyengar Systems pharmacology: network analysis to identify multiscale mechanisms of drug action Annual Review of Pharmacology and Toxicology 52 2012 505 521
58. N.L. Zitomersky, M. Verhave, and C.R. Trenor Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention Inflammatory Bowel Diseases 17 2011 458 470